Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection

NCT07635368 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 630

Last updated 2026-06-09

No results posted yet for this study

Summary

This study seeks to identify and test host protein biomarkers and RNA expression profiles in dried blood spot samples as novel diagnostic markers of congenital cytomegalovirus sequelae and to improve the understanding of the pathogenesis of the disease.

Conditions

  • Congenital Cytomegalovirus
  • Cytomegalovirus Infections
  • Neonatal Infection
  • Sensorineural Hearing Loss
  • Viral Infection

Sponsors & Collaborators

  • Statens Serum Institut

    collaborator OTHER
  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Kia Hee Schultz Dungu, MD · Rigshospitalet, Denmark

  • Ulrikka Nygaard, Ass Prof PhD · Rigshospitalet, Denmark

Eligibility

Min Age
0 Days
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-21
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07635368 on ClinicalTrials.gov